RecruitingNot ApplicableNCT05401669
Transradial Versus Transfemoral Access for Cerebral Angiography
Sponsor
Huashan Hospital
Enrollment
748 participants
Start Date
Sep 15, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This study is multi-center, prospective, randomized (1:1) controlled trial designed to assess and compare the feasibility, safety and success of Transradial access (TRA) versus Transfemoral access (TFA) for diagnostic cerebral angiography.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria5
- Age between 18 and 80 years old;
- Scheduled to undergo diagnostic cerebral angiography;
- Suitable for cerebral angiography via TRA and TFA access, with a radial artery diameter ≥2mm confirmed by ultrasonography;
- Modified Rankin Scale (mRS) score ≤2;
- Provided written informed consent.
Exclusion Criteria9
- Severe stenosis of the radial, brachial, subclavian, brachiocephalic, iliac or common femoral arteries, or any significant vascular disease (such as aortic aneurysm, etc.) that may obstruct guidewire passage;
- Arteriovenous fistula for hemodialysis present in the right upper limb;
- Planned interventional surgery within 24 hours of the initial study angiography;
- Requirement for cerebral angiography in an emergency department;
- Use of general anesthesia;
- Any contraindication to cerebral angiography, such as allergy or intolerance to the contrast media, uncorrected severe coagulation disorders, arterial dissection in the target vessel, puncture site infection, or renal insufficiency (Creatinine \[Gr\] > 3 times of the upper limit of normal \[ULN\]), etc.;
- Women who are pregnant or planning to become pregnant within 1 year;
- Participation in another clinical trial;
- Any other condition deemed unsuitable for participation by the investigator.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURETrans-radial access
Cerebral angiography performed by trans-radial access
PROCEDURETrans-femoral access
Cerebral angiography performed by trans-femoral access
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05401669